Abstract
Tick anticoagulant peptide (TAP) is a potent and selective 60-amino acid inhibitor of the serine protease Factor Xa (fXa), the penultimate enzyme in the blood coagulation cascade. The structural features of TAP responsible for its remarkable specificity for fXa are unknown, but the binding to its target appears to be unique. The elucidation of the TAP structure may facilitate our understanding of this new mode of serine protease inhibition and could provide a basis for the design of novel fXa inhibitors. Analyses of homo- and heteronuclear two-dimensional NMR spectra (total correlation spectroscopy, nuclear Overhauser effect spectroscopy [NOESY], constant time heteronuclear single quantum correlation spectroscopy [CT-HSQC], and HSQC-NOESY; 600 MHz; 1.5 mM TAP; pH 2.5) of unlabeled, 13C-labeled, and 15N-labeled TAP provided nearly complete 1H sequence-specific resonance assignments. Secondary structural elements were identified by characteristic NOE patterns and D2O amide proton-exchange experiments. A three-dimensional structure of TAP was generated from 412 NOESY-derived distance and 47 dihedral angle constraints. The structural elements of TAP are similar in some respects to those of the Kunitz serine protease inhibitor family, with which TAP shares weak sequence homology. This structure, coupled with previous kinetic and biochemical information, confirms previous suggestions that TAP has a unique mode of binding to fXa.
Full Text
The Full Text of this article is available as a PDF (4.3 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Antuch W., Berndt K. D., Chávez M. A., Delfín J., Wüthrich K. The NMR solution structure of a Kunitz-type proteinase inhibitor from the sea anemone Stichodactyla helianthus. Eur J Biochem. 1993 Mar 15;212(3):675–684. doi: 10.1111/j.1432-1033.1993.tb17705.x. [DOI] [PubMed] [Google Scholar]
- Antuch W., Güntert P., Billeter M., Hawthorne T., Grossenbacher H., Wüthrich K. NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata. FEBS Lett. 1994 Sep 26;352(2):251–257. doi: 10.1016/0014-5793(94)00941-4. [DOI] [PubMed] [Google Scholar]
- Bernstein F. C., Koetzle T. F., Williams G. J., Meyer E. F., Jr, Brice M. D., Rodgers J. R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol. 1977 May 25;112(3):535–542. doi: 10.1016/s0022-2836(77)80200-3. [DOI] [PubMed] [Google Scholar]
- Dunwiddie C. T., Neeper M. P., Nutt E. M., Waxman L., Smith D. E., Hofmann K. J., Lumma P. K., Garsky V. M., Vlasuk G. P. Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites. Biochemistry. 1992 Dec 8;31(48):12126–12131. doi: 10.1021/bi00163a022. [DOI] [PubMed] [Google Scholar]
- Dunwiddie C. T., Smith D. E., Nutt E. M., Vlasuk G. P. Anticoagulant effects of the selective factor XA inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibition. Thromb Res. 1991 Dec 15;64(6):787–794. doi: 10.1016/0049-3848(91)90081-7. [DOI] [PubMed] [Google Scholar]
- Hynes T. R., Randal M., Kennedy L. A., Eigenbrot C., Kossiakoff A. A. X-ray crystal structure of the protease inhibitor domain of Alzheimer's amyloid beta-protein precursor. Biochemistry. 1990 Oct 30;29(43):10018–10022. doi: 10.1021/bi00495a002. [DOI] [PubMed] [Google Scholar]
- Jordan S. P., Mao S. S., Lewis S. D., Shafer J. A. Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide. Biochemistry. 1992 Jun 16;31(23):5374–5380. doi: 10.1021/bi00138a019. [DOI] [PubMed] [Google Scholar]
- Jordan S. P., Waxman L., Smith D. E., Vlasuk G. P. Tick anticoagulant peptide: kinetic analysis of the recombinant inhibitor with blood coagulation factor Xa. Biochemistry. 1990 Dec 18;29(50):11095–11100. doi: 10.1021/bi00502a012. [DOI] [PubMed] [Google Scholar]
- Krishnaswamy S., Vlasuk G. P., Bergum P. W. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide. Biochemistry. 1994 Jun 28;33(25):7897–7907. doi: 10.1021/bi00191a017. [DOI] [PubMed] [Google Scholar]
- Laroche Y., Storme V., De Meutter J., Messens J., Lauwereys M. High-level secretion and very efficient isotopic labeling of tick anticoagulant peptide (TAP) expressed in the methylotrophic yeast, Pichia pastoris. Biotechnology (N Y) 1994 Nov;12(11):1119–1124. doi: 10.1038/nbt1194-1119. [DOI] [PubMed] [Google Scholar]
- Neeper M. P., Waxman L., Smith D. E., Schulman C. A., Sardana M., Ellis R. W., Schaffer L. W., Siegl P. K., Vlasuk G. P. Characterization of recombinant tick anticoagulant peptide. A highly selective inhibitor of blood coagulation factor Xa. J Biol Chem. 1990 Oct 15;265(29):17746–17752. [PubMed] [Google Scholar]
- Nutt E., Gasic T., Rodkey J., Gasic G. J., Jacobs J. W., Friedman P. A., Simpson E. The amino acid sequence of antistasin. A potent inhibitor of factor Xa reveals a repeated internal structure. J Biol Chem. 1988 Jul 25;263(21):10162–10167. [PubMed] [Google Scholar]
- Padmanabhan K., Padmanabhan K. P., Tulinsky A., Park C. H., Bode W., Huber R., Blankenship D. T., Cardin A. D., Kisiel W. Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol. 1993 Aug 5;232(3):947–966. doi: 10.1006/jmbi.1993.1441. [DOI] [PubMed] [Google Scholar]
- Sardana M., Sardana V., Rodkey J., Wood T., Ng A., Vlasuk G. P., Waxman L. Determination of disulfide bond pairs and stability in recombinant tick anticoagulant peptide. J Biol Chem. 1991 Jul 25;266(21):13560–13563. [PubMed] [Google Scholar]
- Schaffer L. W., Davidson J. T., Vlasuk G. P., Siegl P. K. Antithrombotic efficacy of recombinant tick anticoagulant peptide. A potent inhibitor of coagulation factor Xa in a primate model of arterial thrombosis. Circulation. 1991 Oct;84(4):1741–1748. doi: 10.1161/01.cir.84.4.1741. [DOI] [PubMed] [Google Scholar]
- Sitko G. R., Ramjit D. R., Stabilito I. I., Lehman D., Lynch J. J., Vlasuk G. P. Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis. Circulation. 1992 Feb;85(2):805–815. doi: 10.1161/01.cir.85.2.805. [DOI] [PubMed] [Google Scholar]
- Szyperski T., Luginbühl P., Otting G., Güntert P., Wüthrich K. Protein dynamics studied by rotating frame 15N spin relaxation times. J Biomol NMR. 1993 Mar;3(2):151–164. doi: 10.1007/BF00178259. [DOI] [PubMed] [Google Scholar]
- Vlasuk G. P., Ramjit D., Fujita T., Dunwiddie C. T., Nutt E. M., Smith D. E., Shebuski R. J. Comparison of the in vivo anticoagulant properties of standard heparin and the highly selective factor Xa inhibitors antistasin and tick anticoagulant peptide (TAP) in a rabbit model of venous thrombosis. Thromb Haemost. 1991 Mar 4;65(3):257–262. [PubMed] [Google Scholar]
- Vlasuk G. P. Structural and functional characterization of tick anticoagulant peptide (TAP): a potent and selective inhibitor of blood coagulation factor Xa. Thromb Haemost. 1993 Jul 1;70(1):212–216. [PubMed] [Google Scholar]
- Wagner G., Wüthrich K. Sequential resonance assignments in protein 1H nuclear magnetic resonance spectra. Basic pancreatic trypsin inhibitor. J Mol Biol. 1982 Mar 5;155(3):347–366. doi: 10.1016/0022-2836(82)90009-2. [DOI] [PubMed] [Google Scholar]
- Waxman L., Smith D. E., Arcuri K. E., Vlasuk G. P. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science. 1990 May 4;248(4955):593–596. doi: 10.1126/science.2333510. [DOI] [PubMed] [Google Scholar]
- Wun T. C., Kretzmer K. K., Girard T. J., Miletich J. P., Broze G. J., Jr Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem. 1988 May 5;263(13):6001–6004. [PubMed] [Google Scholar]